Dexcom (DXCM) 92.09 $DXCM DexCom Announces Upco
Post# of 273323
Posted On: 09/03/2016 11:20:01 AM
Dexcom (DXCM) 92.09 $DXCM
DexCom Announces Upcoming Conference Presentation
BusinessWire - Thu Sep 01, 3:30PM CDT
DexCom, Inc. (NASDAQ
XCM) today announced that management will present an update on DexCom at the following upcoming investor conference:
DXCM: 92.09 (+0.38)
New Wearable Devices in the Medical and Diagnostic Sectors
PR Newswire - Tue Aug 30, 8:00AM CDT
A new segment of the wearable devices market is emerging and it is with a focus on medical and diagnostic purposes. The diagnostic wearable medical devices are using technology to remotely monitor, control, and track individual's vital signs. According to a recent report by Researchmoz, the global diagnostic wearable medical devices market is set to grow at a CAGR of 14.01% during the period 2016-2020. Biotricity Inc. (OTCQB: BTCY), DexCom, Inc. (NASDAQ: DXCM), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL), Fitbit Inc. (NASDAQ: FIT).
FIT: 14.96 (+0.01), DXCM: 92.09 (+0.38), GOOGL: 796.87 (+5.47)
DexCom Up 36.4% Since SmarTrend Uptrend Call (DXCM)
Comtex SmarTrend(R) - Mon Aug 29, 1:08PM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQXCM) on June 3rd, 2016 at $67.24. In approximately 3 months, DexCom has returned 36.43% as of today's recent price of $91.74.
DXCM: 92.09 (+0.38)
Research Report Initiation on These Healthcare Stocks -- VWR Corp., DexCom, Laboratory Corp. of America, and PerkinElmer
PR Newswire - Thu Aug 25, 7:00AM CDT
Operators in the Medical Laboratories and Research segment provide healthcare practitioners with information concerning the onset, severity, and cause of patients' ailments and illnesses. Equities under evaluation on Stock-Callers.com are: VWR Corp. (NASDAQ: VWR), DexCom Inc. (NASDAQ: DXCM), Laboratory Corp. of America Holdings (NYSE: LH), and PerkinElmer Inc. (NYSE: PKI). Learn more about these stocks by downloading their free report at:
DXCM: 92.09 (+0.38), VWR: 27.79 (+0.04), LH: 137.71 (+1.58), PKI: 53.46 (+0.20)
DexCom Set to Possibly Pullback After Yesterday's Rally of 1.21%
Comtex SmarTrend(R) - Wed Aug 24, 1:33PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $91.63 to a high of $93.87. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $92.25 on volume of 438,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 92.09 (+0.38)
Shares of DXCM Up 34.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 19, 1:12PM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQXCM) on June 3rd, 2016 at $67.24. In approximately 3 months, DexCom has returned 34.27% as of today's recent price of $90.29.
DXCM: 92.09 (+0.38)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 4:34PM CDT
The MiniMed 630G basically combines SmartGuard technology which is already featured in the MiniMed 530G system with a brand new user-friendly design.
ABT: 42.09 (-0.21), BDX: 177.32 (+0.30), DXCM: 92.09 (+0.38), MDT: 87.32 (+0.34)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:15AM CDT
Medtronic plc's (MDT) MiniMed 630G system with SmartGuard technology recently won the U.S. FDA approval for its commercial launch.
ABT: 42.09 (-0.21), BDX: 177.32 (+0.30), DXCM: 92.09 (+0.38), MDT: 87.32 (+0.34)
Uptrend Call Working As DexCom Stock Rises 35.3% (DXCM)
Comtex SmarTrend(R) - Fri Aug 12, 12:41AM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQXCM) on June 3rd, 2016 at $67.24. In approximately 2 months, DexCom has returned 35.31% as of today's recent price of $90.99.
DXCM: 92.09 (+0.38)
After Yesterday's Decline of 1.02%, DexCom Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 10, 2:16PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $89.17 to a high of $90.96. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $90.48 on volume of 442,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
DXCM: 92.09 (+0.38)
DexCom Launches New Clinic Portal for the DexCom CLARITY® Diabetes Management Solution
PR Newswire - Mon Aug 08, 7:10AM CDT
DexCom, Inc., (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, today announced the availability of enhanced data sharing features for physician and patient users of the DexCom CLARITY® diabetes management solution. The cloud-based solution simplifies CGM data reporting and management, and now facilitates the secure sharing of data between physicians and their patients enabling both to gain quick access to important insights that can be used to assess treatment outcomes. DexCom CLARITY works with the DexCom G5® Mobile Continuous Glucose Monitoring System by automatically sending a patient's CGM data to a secure cloud-based system that can easily be accessed by the patient's health care professional.
DXCM: 92.09 (+0.38)
DexCom (DXCM) Q2 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 10:18AM CDT
DexCom Inc. (DXCM) reported loss of 24 cents per share in the second quarter of 2016, much wider than the Zacks Consensus Estimate of a loss of 11 cents.
BABY: 40.64 (+0.93), DXCM: 92.09 (+0.38), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
DexCom, Inc. Reports Second Quarter 2016 Financial Results
BusinessWire - Tue Aug 02, 3:01PM CDT
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2016.
DXCM: 92.09 (+0.38)
Look at Aug 2 Medical Instrument Earnings: IDXX, DXCM, CGNT
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:07AM CDT
Medical, one of the 16 broader Zacks sectors, has so far exhibited a promising performance.
DXCM: 92.09 (+0.38), IDXX: 114.09 (+0.93), CGNT: 1.22 (+0.06)
SmarTrend Watching for Potential Pullback in Shares of DexCom After 1.32% Gain
Comtex SmarTrend(R) - Wed Jun 01, 2:07PM CDT
DexCom (NASDAQXCM) traded in a range yesterday that spanned from a low of $62.68 to a high of $65.60. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $65.43 on volume of 718,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
DXCM: 92.09 (+0.38)
DexCom Announces Upcoming Conference Presentation
BusinessWire - Thu Sep 01, 3:30PM CDT
DexCom, Inc. (NASDAQ
XCM) today announced that management will present an update on DexCom at the following upcoming investor conference: DXCM: 92.09 (+0.38)
New Wearable Devices in the Medical and Diagnostic Sectors
PR Newswire - Tue Aug 30, 8:00AM CDT
A new segment of the wearable devices market is emerging and it is with a focus on medical and diagnostic purposes. The diagnostic wearable medical devices are using technology to remotely monitor, control, and track individual's vital signs. According to a recent report by Researchmoz, the global diagnostic wearable medical devices market is set to grow at a CAGR of 14.01% during the period 2016-2020. Biotricity Inc. (OTCQB: BTCY), DexCom, Inc. (NASDAQ: DXCM), Siemens AG (OTC: SIEGY), Alphabet Inc. (NASDAQ: GOOGL), Fitbit Inc. (NASDAQ: FIT).
FIT: 14.96 (+0.01), DXCM: 92.09 (+0.38), GOOGL: 796.87 (+5.47)
DexCom Up 36.4% Since SmarTrend Uptrend Call (DXCM)
Comtex SmarTrend(R) - Mon Aug 29, 1:08PM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQ
XCM) on June 3rd, 2016 at $67.24. In approximately 3 months, DexCom has returned 36.43% as of today's recent price of $91.74. DXCM: 92.09 (+0.38)
Research Report Initiation on These Healthcare Stocks -- VWR Corp., DexCom, Laboratory Corp. of America, and PerkinElmer
PR Newswire - Thu Aug 25, 7:00AM CDT
Operators in the Medical Laboratories and Research segment provide healthcare practitioners with information concerning the onset, severity, and cause of patients' ailments and illnesses. Equities under evaluation on Stock-Callers.com are: VWR Corp. (NASDAQ: VWR), DexCom Inc. (NASDAQ: DXCM), Laboratory Corp. of America Holdings (NYSE: LH), and PerkinElmer Inc. (NYSE: PKI). Learn more about these stocks by downloading their free report at:
DXCM: 92.09 (+0.38), VWR: 27.79 (+0.04), LH: 137.71 (+1.58), PKI: 53.46 (+0.20)
DexCom Set to Possibly Pullback After Yesterday's Rally of 1.21%
Comtex SmarTrend(R) - Wed Aug 24, 1:33PM CDT
DexCom (NASDAQ
XCM) traded in a range yesterday that spanned from a low of $91.63 to a high of $93.87. Yesterday, the shares gained 1.2%, which took the trading range above the 3-day high of $92.25 on volume of 438,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DXCM: 92.09 (+0.38)
Shares of DXCM Up 34.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Aug 19, 1:12PM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQ
XCM) on June 3rd, 2016 at $67.24. In approximately 3 months, DexCom has returned 34.27% as of today's recent price of $90.29. DXCM: 92.09 (+0.38)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care (revised)
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 4:34PM CDT
The MiniMed 630G basically combines SmartGuard technology which is already featured in the MiniMed 530G system with a brand new user-friendly design.
ABT: 42.09 (-0.21), BDX: 177.32 (+0.30), DXCM: 92.09 (+0.38), MDT: 87.32 (+0.34)
Medtronic Launches MiniMed 630G, Expands in Diabetic Care
Zacks Equity Research - Zacks Investment Research - Mon Aug 15, 9:15AM CDT
Medtronic plc's (MDT) MiniMed 630G system with SmartGuard technology recently won the U.S. FDA approval for its commercial launch.
ABT: 42.09 (-0.21), BDX: 177.32 (+0.30), DXCM: 92.09 (+0.38), MDT: 87.32 (+0.34)
Uptrend Call Working As DexCom Stock Rises 35.3% (DXCM)
Comtex SmarTrend(R) - Fri Aug 12, 12:41AM CDT
SmarTrend identified an Uptrend for DexCom (NASDAQ
XCM) on June 3rd, 2016 at $67.24. In approximately 2 months, DexCom has returned 35.31% as of today's recent price of $90.99. DXCM: 92.09 (+0.38)
After Yesterday's Decline of 1.02%, DexCom Offers Investors Better Value
Comtex SmarTrend(R) - Wed Aug 10, 2:16PM CDT
DexCom (NASDAQ
XCM) traded in a range yesterday that spanned from a low of $89.17 to a high of $90.96. Yesterday, the shares fell 1.0%, which took the trading range below the 3-day low of $90.48 on volume of 442,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion. DXCM: 92.09 (+0.38)
DexCom Launches New Clinic Portal for the DexCom CLARITY® Diabetes Management Solution
PR Newswire - Mon Aug 08, 7:10AM CDT
DexCom, Inc., (NASDAQ: DXCM), a leader in continuous glucose monitoring (CGM) for patients with diabetes, today announced the availability of enhanced data sharing features for physician and patient users of the DexCom CLARITY® diabetes management solution. The cloud-based solution simplifies CGM data reporting and management, and now facilitates the secure sharing of data between physicians and their patients enabling both to gain quick access to important insights that can be used to assess treatment outcomes. DexCom CLARITY works with the DexCom G5® Mobile Continuous Glucose Monitoring System by automatically sending a patient's CGM data to a secure cloud-based system that can easily be accessed by the patient's health care professional.
DXCM: 92.09 (+0.38)
DexCom (DXCM) Q2 Loss Wider than Expected, Stock Down
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 10:18AM CDT
DexCom Inc. (DXCM) reported loss of 24 cents per share in the second quarter of 2016, much wider than the Zacks Consensus Estimate of a loss of 11 cents.
BABY: 40.64 (+0.93), DXCM: 92.09 (+0.38), MASI: 59.90 (+0.47), CPHD: 34.42 (+0.16)
DexCom, Inc. Reports Second Quarter 2016 Financial Results
BusinessWire - Tue Aug 02, 3:01PM CDT
DexCom, Inc. (Nasdaq: DXCM) today reported its unaudited financial results as of and for the quarter ended June 30, 2016.
DXCM: 92.09 (+0.38)
Look at Aug 2 Medical Instrument Earnings: IDXX, DXCM, CGNT
Zacks Equity Research - Zacks Investment Research - Mon Aug 01, 7:07AM CDT
Medical, one of the 16 broader Zacks sectors, has so far exhibited a promising performance.
DXCM: 92.09 (+0.38), IDXX: 114.09 (+0.93), CGNT: 1.22 (+0.06)
SmarTrend Watching for Potential Pullback in Shares of DexCom After 1.32% Gain
Comtex SmarTrend(R) - Wed Jun 01, 2:07PM CDT
DexCom (NASDAQ
XCM) traded in a range yesterday that spanned from a low of $62.68 to a high of $65.60. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $65.43 on volume of 718,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious. DXCM: 92.09 (+0.38)
(0)
(0)